Project Grant R15DE035277
Award Date 8/14/25
Completion Date 8/13/28
Dollars Obligated $584K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
- This Project Grant award was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121). The $101,356 grant, awarded on Sep 1, 2025, supports research by Nova Southeastern University, Inc. to investigate the role of the PIEZO1 mechanosensitive receptor in regulating the formation of specialized type H blood vessels that support bone regeneration in periodontitis, a chronic inflammatory disease....
- The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), awarded a $298,942 Project Grant to Deltamed LLC on August 20, 2025. The grant funding will support the development of a novel "nanosponge prodrug delivery system" for the small molecule MK2 inhibitors apatinib and MMI-0100. The goal is to improve the circulation half-life and targeted delivery of these compounds to mitigate...
- This Project Grant award, funded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), supports the co-development of autologous oral mucosal grafts for therapeutic purposes. The $1,240,877 award to Cedars-Sinai Medical Center aims to engineer vascularized, functional oral tissue grafts that can be tailored to diverse clinical needs, leveraging advances in single cell/spatial multiomics, developmental...
- The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), awarded a $273,009 Project Grant to Virginia Commonwealth University (VCU) to characterize a conserved streptococcal membrane protein affecting manganese utilization. The project aims to determine the crystal structure and functional role of this membrane protein, hypothesized to be an acyltransferase that incorporates polyunsaturated fatty acids...
- This Project Grant, awarded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), supports research to develop a novel 3D-printed mineral framework and cryogel scaffold to improve bone regeneration in head and neck cancer patients suffering from radiation-induced osteoradionecrosis. The $533,675 grant, with a performance period from July 1, 2025 to March 31, 2030, aims to test the central...
- The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $685,594 Project Grant under the Oral Diseases and Disorders Research (CFDA 93.121) program to The Pennsylvania State University (Penn State) to support research on leveraging microsurgery and bioprinting to enable rapidly vascularized tissue engineering for craniomaxillofacial (CMF) injury reconstruction. The project aims to advance a novel microsurgical "vascular micropuncture" technique to enhance the...
- The federal Project Grant award in the amount of $613,736 was provided by the National Institute of Dental and Craniofacial Research (NIDCR), which administers the Oral Diseases and Disorders Research federal grant program (CFDA 93.121). The grant was awarded to Cayman Chemical Co Inc., a for-profit company located in Ann Arbor, Michigan, to develop novel osteogenic small-molecule pharmacotherapies for dental bone regeneration. Specifically, Cayman Chemical will create novel EZH2 inhibitor...
- The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $1,952,000 Project Grant under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121) to Matregenix Inc., a small disadvantaged business located in California. The grant supports the development of MATRINOVA, an animal-free, amino acid-based biodegradable barrier membrane for guided bone regeneration in dental and craniomaxillofacial surgeries. The research aims to create a membrane with a unique...
- This federal Project Grant award for $1 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program. The grant supports research to establish generalizable genome editing strategies that could be broadly applicable to treat hundreds of rare disease-causing genetic variants. The proposed work will address rare loss-of-function alleles and rare gain-of-function alleles, and will be studied in the context of...
- The federal Project Grant award of $424,560.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to investigate the effects of the phytochemical hesperidin on bone regeneration and bone morphogenetic protein (BMP) function. The award funds the development of a 3D co-culture platform that mimics the bone microenvironment to study hesperidin's impact on inflammatory response,...